The evolution of antiviral therapy for external ocular viral infections over twenty-five years

Cornea

Volumn 19, Issue 5, 2000, Pages 673-680

  Gordon, Y Jerold ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenovirus; Antiviral; EKC; Herpes simplex virus; Herpes zoster ophthalmicus; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; 9 (4 HYDROXYBUTYL) N PHENYLGUANINE; ACICLOVIR; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIVIRUS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHICKENPOX VACCINE; CIDOFOVIR; CORTICOSTEROID; CORYNANTHINE; CYTARABINE; FAMCICLOVIR; FLUOROURACIL; FOSCARNET; GANCICLOVIR; GANGLION BLOCKING AGENT; HERPES SIMPLEX VACCINE; HYPERIMMUNE GLOBULIN; IDOXURIDINE; INACTIVATED VIRUS VACCINE; NUCLEOSIDE ANALOG; PENCICLOVIR; PREDNISOLONE 21 PHOSPHATE; PROPRANOLOL; SORIVUDINE; THYMOXINE; TRIFLURIDINE; UNCLASSIFIED DRUG; VALACICLOVIR; VIDARABINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADENOVIRUS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG STRUCTURE; EYE INFECTION; EYE TOXICITY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HERPES ZOSTER OPHTHALMICUS; HISTORY; HUMAN; IRITIS; KERATOCONJUNCTIVITIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; UVEITIS; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS INFECTION;

ANTIVIRAL AGENTS; EYE INFECTIONS, VIRAL; HISTORY, 20TH CENTURY; HUMANS; OPHTHALMOLOGY;

EID: 0033822455     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-200009000-00012     Document Type: Review

References (73)

1. Synthesis and biologic activities of isododeoxyuridine, an analog of thymidine
2. Use of 5-iodo-2'-deoxyuridine (IDU) treatment of herpes simplex keratitis
3. Clinical cure of herpes simplex keratitis by 5-iodo-2'-deoxyuridine
4. Antiviral drugs
5. Recent advances in antiviral therapy
6. The management of ocular herpes virus infections
7. Clinical evaluation of trifluridine in the treatment of herpes simplex corneal ulcers
8. Efficacy of acycloguanosine (Wellcome 248u) against herpes simplex corneal ulceration
9. Antiviral therapy of herpes simplex and varicella-zoster virus infections
10. Ganciclovir ophthalmic gel (Virgan: 0.15%) in the treatment of herpes simplex keratitis
11. Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis
12. The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731): A potential topical therapy for herpes simplex virus infection
13. Viral targets for antisense oligonucleotides: A mini review
14. Herpes simplex eye infections: Clinical manifestations, pathogenesis and management
15. Iritis due to herpes virus
16. The clinical features of viral keratitis and a concept of their pathogenesis
17. Immunology of herpes virus infection
18. An immunologist's view of herpes simplex keratitis
19. Interleukin 10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1
20. Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10
21. Molecular mimicry by herpes simplex virus type 1: Autoimmune disease after viral infection
22. Current therapy of herpes simplex virus infection of the cornea
23. Herpetic Eye Disease Study: A controlled trial of topical corticosteroids for herpes simplex stromal keratitis
24. Herpetic Eye Disease Study: A controlled trial of oral acyclovir for herpes simplex stromal keratitis
25. A controlled trial of oral acyclovir for the prevention of stromal keratitis or iritis in patients with herpes simplex virus epithelial keratitis
26. Evaluation of topical 0.03% flubiprofen drops in the treatment of herpetic stromal keratitis
27. Effects of DHPG eye drops and cyclosporine eye drops in the treatment of herpetic stromal keratitis in rabbits
28. Prophylactic topical cyclosporine in experimental herpetic stromal keratitis
29. Treatment of HSV-1 stromal keratitis with topical cyclosporin A: A pilot study
30. Oral acyclovir (Zovirax) in herpes simplex dendritic corneal ulceration
31. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus
32. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection
33. Suppression of frequently recurring genital herpes: A placebo-controlled double-blind trial of oral acyclovir
34. Acyclovir prevents reactivation of herpes labialis in skiers
35. Continuous five-year treatment of patients with frequently recurring genital herpes simplex virus infection with acyclovir
36. Acyclovir suppression to prevent cesarian delivery after first episode genital herpes
37. Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes
38. Oral famvir for suppression of recurrent genital herpes simplex virus infections in women
39. Oral acyclovir in the management of herpes simplex ocular infections
40. Effect of recurrent infectious herpes simplex keratitis in patients with and without grafts
41. A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis
42. Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis
43. Valacyclovir inhibits recovery of ocular HSV-1 after experimental reactivation by excimer laser keratectomy
44. Acyclovir for the prevention of recurrent herpes simplex virus eye disease Herpetic Eye Disease Study Group
45. HSV-1 migration in latently infected and naive rabbits after penetrating keratoplasty
46. Tissue-specific accumulation of latency-associated transcripts in herpes virus infected rabbits
47. Herpes simplex virus type 1 transcription is not detectable in quiescent stromal keratitis by in situ hybridization
48. HSV-stromal keratitis: A new molecular model and its clinical correlation
49. Herpes simplex virus in the trabeculum of an eye with corneal endotheliitis
50. Herpes simplex virus isolations from the aqueous of patients suffering from focal iritis, endotheliitis, and prolonged disciform keratitis with glaucoma
51. Recurrence rate of herpetic uveitis in patients on long-term oral acyclovir
52. Herpes simplex virus vaccines
53. Herpesvirus vaccines
54. Vaccine development
55. Effect of 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG): A thymidine kinase inhibitor, on clinical recurrences of ocular herpetic keratitis in squirrel monkeys
56. 9-(4-hydroxybutyl)-N2-phenylguanine (HBPG): A thymidine kinase inhibitor, suppresses herpes virus reactivation in mice
57. The effect of alpha blockade on iontophoresis-induced ocular shedding of latent HSV-1 W in different host animals
58. Propranolol suppresses reactivation of herpesvirus
59. Varicella-zoster eye disease
60. Viral disease of the cornea and external eye
61. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus
62. Influence of oral acyclovir on ocular complications of herpes zoster ophthalmicus
63. Oral acyclovir for herpes zoster ophthalmicus
64. Herpes zoster ophthalmicus in patients with human immunodeficiency virus infection
65. Recent advances in varivella-zoster infection
66. Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
67. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia
68. Manifestations resembling thrombotic microangiopathy in patients with advanced human immunodeficiency virus disease in cytomegalovirus prophylaxis trial (ACTG 204)
69. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in HIV-infected patients
70. Update on varicella vaccine
71. Adenovirus keratoconjunctivitis